title: [Resorptive lymphadenitis after portal embolisation for hilar cholangiocarcinoma].
authors.forename: David
authors.initials: D
authors.lastname: Fuks
authors.forename: Denis
authors.initials: D
authors.lastname: Chatelain
authors.forename: Marie
authors.initials: M
authors.lastname: Holvöet
authors.forename: Charles
authors.initials: C
authors.lastname: Sabbagh
authors.forename: Frédéric
authors.initials: F
authors.lastname: Dumont
authors.forename: Olivier
authors.initials: O
authors.lastname: Bréhant
authors.forename: Thierry
authors.initials: T
authors.lastname: Yzet
authors.forename: Richard
authors.initials: R
authors.lastname: Delcenserie
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Regimbeau
mesh_terms: D001650:Bile Duct Neoplasms / Q000628:therapy*; D001653:Bile Ducts, Intrahepatic; D018281:Cholangiocarcinoma / Q000628:therapy*; D004621:Embolization, Therapeutic / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008199:Lymphadenitis / Q000209:etiology*; D008875:Middle Aged; D011169:Portal Vein